Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Addressing challenges in the treatment of tuberculosis and tuberculosis meningitis: a pharmacometric approach
Tuberculosis (TB) is the primary cause of death from a single infectious agent worldwide. During the coronavirus disease (COVID-19) pandemic, TB briefly fell to second place, but it has now regained its position as the top infectious killer. It is caused by Mycobacterium tuberculosis and mainly targ...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English English |
| Published: |
Department of Medicine
2025
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Addressing challenges in the treatment of tuberculosis and tuberculosis meningitis: a pharmacometric approach
- Advancing tuberculosis treatment through pharmacometric modeling of drug exposure and biomarkers
- Pharmacometrics to characterize pharmacokinetics and optimize treatment in understudied populations
- Pharmacometrics of dolutegravir and tenofovir: a quantitative approach to characterise drug-drug interactions, pharmacogenetics and optimise treatment
- Pharmacometric modelling to inform and improve TB and HIV treatment: Focus on drug-drug interactions and neglected populations
- Population pharmacokinetic and pharmacodynamic modelling to improve tuberculosis treatment
- Simultaneous quantification of first-line anti-tuberculosis drugs and metabolites in human plasma